Assessment of Diabetes Risk in Patients With Hepatitis B: A Machine Learning Approach Integrating 11 Inflammatory and Immune Indicators
Diabetes/Metabolism Research and Reviews · 2026-07 · 42 (5)
DOI: 10.1002/dmrr.70193 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes/Metabolism Research and Reviews, online erschienen am 09.07.2026. Verfasst von Zhisheng Cai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Jinjiang Municipal Hospital, Quanzhou, Fujian, China. Hauptthemen laut MEDLINE: Machine Learning, Diabetes Mellitus, Inflammation, Biomarkers. Die Arbeit nennt 21 Literaturangaben.
Themen: Künstliche Intelligenz in der Pflege, Diabetes mellitus
Abstract (Originalsprache)
Background
Chronic hepatitis B virus (HBV) infection is associated with an increased risk of diabetes; however, early detection of diabetes remains challenging due to silent progression in early stages. Given that 30%–50% of diabetic patients develop severe complications such as cardiovascular disease, renal failure, and neuropathy, timely risk assessment is critical for prevention.
Methods
We developed a machine learning model using data from 14,287 HBV‐positive adults across eight NHANES cycles (2003–2018) to identify diabetes. Eleven inflammation‐immune composite indicators were integrated with demographic and biochemical parameters. Following LASSO variable selection and a 7:3 train‐test split, seven algorithms were compared. Model performance was evaluated using the area under the ROC curve (AUC), calibration curve, and decision curve analysis (DCA).
Results
The Artificial Neural Network (ANN) emerged as the optimal model for diabetes risk assessment. It achieved an AUC of 0.83 (95% CI: 0.80–0.85) and an accuracy of 82% (95% CI: 0.79–0.85). SHAP analysis identified age and UHR as the most influential predictors, while HRR showed significant protective effects.
Conclusion
This study presents a robust, interpretable model for diabetes risk assessment in HBV patients that integrates novel inflammation‐immune composite indicators. These findings highlight the model's utility as a potential clinical tool for screening individuals with undiagnosed diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jinjiang Municipal Hospital, Quanzhou, Fujian, China.
- School of Basic Medical Sciences, China Three Gorges University, Yichang, China.
ORCID-Profile: Tengyue Zhang, Yangyi Zhang, Junjie Liu
Zitieren
APA
Cai, Z., Liu, J., Zhang, W., Lu, Y., Su, Y., Zhang, T., Zhang, Y., Wang, X., Ye, L., Tao, Y., & Liu, J. (2026). Assessment of Diabetes Risk in Patients With Hepatitis B: A Machine Learning Approach Integrating 11 Inflammatory and Immune Indicators. Diabetes/Metabolism Research and Reviews, 42(5). https://doi.org/10.1002/dmrr.70193
Vancouver
Cai Z, Liu J, Zhang W, Lu Y, Su Y, Zhang T, et al. Assessment of Diabetes Risk in Patients With Hepatitis B: A Machine Learning Approach Integrating 11 Inflammatory and Immune Indicators. Diabetes/Metabolism Research and Reviews. 2026;42(5). doi:10.1002/dmrr.70193
BibTeX
@article{Cai2026,
author = {Cai, Zhisheng and Liu, Jingtao and Zhang, Wenjie and Lu, Yutong and Su, Yumeng and Zhang, Tengyue and Zhang, Yangyi and Wang, Xiaochi and Ye, Linyi and Tao, Ying and Liu, Junjie},
title = {Assessment of Diabetes Risk in Patients With Hepatitis B: A Machine Learning Approach Integrating 11 Inflammatory and Immune Indicators},
journal = {Diabetes/Metabolism Research and Reviews},
year = {2026},
volume = {42},
number = {5},
doi = {10.1002/dmrr.70193}
}
EUVIMED